Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_assertion type Assertion NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_head.
- NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_assertion description "[We, thus, analysed serum HE4 concentrations together with a tumour marker CA125 in serum samples of women diagnosed with various types of endometriosis, endometrial cancer or ovarian cancer, and in samples from healthy controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_provenance.
- NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_assertion evidence source_evidence_literature NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_provenance.
- NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_assertion SIO_000772 19337252 NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_provenance.
- NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_assertion wasDerivedFrom befree-20150227 NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_provenance.
- NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_assertion wasGeneratedBy ECO_0000203 NP542727.RAivkka4Xdc9Lb8LLjmpvDwYyKoSsjjigkn3F2_ANWJUA130_provenance.